Drug · DIN 02519178
BICALUTAMIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 28, 2022; first marketed April 28, 2022.
- Drug Identification Number (DIN)
- 02519178
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bicalutamide L02BB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BICALUTAMIDE | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 18, 2021: NOC 26466Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named BICALUTAMIDE
- DIN 02325233 · Cancelled Post Market
- DIN 02382423 · Cancelled Post Market